Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function

Supplementary Data

Files in this Data Supplement:

This Article

  1. Diabetes September 2012 vol. 61 no. 9 2340-2348
  1. » Supplementary Data